Europeiska unionen - engelska - EMA (European Medicines Agency)

janssen-cilag international n.v.   - paliperidone palmitate - schizophrenia - psycholeptics - byannli (previously paliperidone janssen-cilag international) a 6 monthly injection, is indicated for the maintenance treatment of schizophrenia in adult patients who are clinically stable on 1 monthly or 3 monthly paliperidone palmitate injectable products (see section 5.1).

Kanada - engelska - Health Canada

mylan pharmaceuticals ulc - paliperidone - tablet (extended-release) - 3mg - paliperidone 3mg - atypical antipsychotics

Kanada - engelska - Health Canada

mylan pharmaceuticals ulc - paliperidone - tablet (extended-release) - 6mg - paliperidone 6mg - atypical antipsychotics

Kanada - engelska - Health Canada

marcan pharmaceuticals inc - paliperidone - tablet (extended-release) - 3mg - paliperidone 3mg - atypical antipsychotics

Kanada - engelska - Health Canada

marcan pharmaceuticals inc - paliperidone - tablet (extended-release) - 6mg - paliperidone 6mg - atypical antipsychotics

Kanada - engelska - Health Canada

marcan pharmaceuticals inc - paliperidone - tablet (extended-release) - 9mg - paliperidone 9mg - atypical antipsychotics

Australien - engelska - Department of Health (Therapeutic Goods Administration)

janssen-cilag pty ltd - paliperidone palmitate -

Australien - engelska - Department of Health (Therapeutic Goods Administration)

janssen-cilag pty ltd - paliperidone palmitate -

Australien - engelska - Department of Health (Therapeutic Goods Administration)

janssen-cilag pty ltd - paliperidone palmitate -

Australien - engelska - Department of Health (Therapeutic Goods Administration)

janssen-cilag pty ltd - paliperidone palmitate -